ARCHIVES

Two-Year Remission While Taking Gleevec Puts Patients Into Normal Mortality Rate

This article is from The Cancer Letter archive.

Vol. 34 No. 3 | March 25, 2011

Download PDF Visit The Full Archive

Related Articles

Unclear Whether Clinical Trials Benefit Patients, Review Finds

February 27, 2004

In Brief: UC Irvine Wins Grant For Trial Of One-Visit Cervical Cancer Screening, Treatment

November 6, 1998

In Brief: Calabresi Named To President’s Cancer Panel; Mays Leaves NCI Technology Office For IVAX

May 5, 1995

In Brief: Rosenberg To Give Karnofsky Lecture at ASCO, Minna To Present Rosenthal Lecture At AACR

April 27, 1984

Peters Replaced As Director Of Karmanos Cancer Center.

December 1, 2000

DCE Board Approves concept For New Studies On Black, White Differences In Cancer Rates

July 13, 1984